Ozempic and Wegovy are different medications, but they share the same active ingredient, semaglutide. The main difference is that Ozempic is taken to treat type 2 diabetes, while Wegovy is for weight management. It’s worth noting that Ozempic is also being prescribed for weight management.
The two medications can also result in gastroparesis, bowel obstruction, and vision loss. Lawsuits against the manufacturer, Novo Nordisk, are being filed on the grounds that they failed to warn the public about these risks.
People who’ve been taking Ozempic and Wegovy and are now suffering from the linked illnesses are recommended to file a lawsuit against Novo Nordisk. We can help you get started if you think you’re a potential claimant. Reach out to our team, and they’ll assess your case. If you’re eligible for a claim, we’ll help you out further by putting you in contact with an expert semaglutide attorney.